Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback